Q2 2018 13F Holders as of 6/30/2018
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
104M
-
Number of holders
-
24
-
Total 13F shares, excl. options
-
4.44M
-
Shares change
-
-225K
-
Total reported value, excl. options
-
$8.89M
-
Value change
-
-$485K
-
Number of buys
-
7
-
Number of sells
-
-9
-
Price
-
$2.00
Significant Holders of VOLITIONRX LTD - Common Stock, par value $0.001 per share (VNRX) as of Q2 2018
28 filings reported holding VNRX - VOLITIONRX LTD - Common Stock, par value $0.001 per share as of Q2 2018.
VOLITIONRX LTD - Common Stock, par value $0.001 per share (VNRX) has 24 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 4.44M shares
of 104M outstanding shares and own 4.29% of the company stock.
Largest 10 shareholders include Lagoda Investment Management, L.P. (3.12M shares), Knoll Capital Management, LP (352K shares), VANGUARD GROUP INC (298K shares), BRIDGEWAY CAPITAL MANAGEMENT INC (199K shares), GEODE CAPITAL MANAGEMENT, LLC (101K shares), MORGAN STANLEY (84.2K shares), CREDIT SUISSE AG/ (65K shares), NORTHERN TRUST CORP (38K shares), OPPENHEIMER & CO INC (37K shares), and Skylands Capital, LLC (30.9K shares).
This table shows the top 24 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.